PRTA
Prothena Corporation PLC
Price:  
6.82 
USD
Volume:  
1,134,995.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTA EV/EBITDA

-403.3%
Upside

As of 2025-05-22, the EV/EBITDA ratio of Prothena Corporation PLC (PRTA) is 0.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTA's latest enterprise value is -50.81 mil USD. PRTA's TTM EBITDA according to its financial statements is -137.96 mil USD. Dividing these 2 quantities gives us the above PRTA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.7x - 14.3x 10.9x
Forward P/E multiples 9.0x - 16.2x 11.3x
Fair Price (15.40) - (28.89) (20.68)
Upside -325.9% - -523.5% -403.3%
6.82 USD
Stock Price
(20.68) USD
Fair Price

PRTA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-21 0.39
2025-05-20 0.18
2025-05-19 0.14
2025-05-16 0.23
2025-05-15 0.41
2025-05-14 0.34
2025-05-13 0.07
2025-05-12 0.06
2025-05-09 0.13
2025-05-08 0.26
2025-05-07 0.18
2025-05-06 0.16
2025-05-05 -0.12
2025-05-02 -0.29
2025-05-01 -0.37
2025-04-30 -0.56
2025-04-29 -0.75
2025-04-28 -0.74
2025-04-25 -0.76
2025-04-24 -0.74
2025-04-23 -0.71
2025-04-22 -0.69
2025-04-21 -0.60
2025-04-17 -0.56
2025-04-16 -0.58
2025-04-15 -0.71
2025-04-14 -0.85
2025-04-11 -0.96
2025-04-10 -0.75
2025-04-09 -0.97
2025-04-08 -1.06
2025-04-07 -1.20
2025-04-04 -1.21
2025-04-03 -1.39
2025-04-02 -1.71
2025-04-01 -1.55
2025-03-31 -1.80
2025-03-28 -2.10
2025-03-27 -2.05
2025-03-26 -2.19
2025-03-25 -1.91
2025-03-24 -2.18
2025-03-21 -2.03
2025-03-20 -1.99
2025-03-19 -2.00
2025-03-18 -1.98
2025-03-17 -2.33
2025-03-14 -2.33
2025-03-13 -2.46
2025-03-12 -2.38